Skip to main content

Table 2 Socio-demographic characteristics of the 412 DLBCL patients with data on RDI included in the AMARE cohort study and comparisons between RDI groups

From: A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival

  

Total

RDI < 85% (n = 72)

RDI ≥ 85% (n = 340)

P valuea

  

n

%

n

%

n

%

Occupational status

active

123

29.9

22

30.6

101

29.7

0.861

inactive/retired

268

65.1

46

63.9

222

65.3

 

missing

21

5.1

4

5.6

17

5

 

Cohabiting status

not alone

253

61.4

41

56.9

212

62.4

0.271

alone

125

30.3

26

36.1

99

29.1

 

missing

34

8.3

5

6.9

29

8.5

 

Socioeconomic status (quintile of EDI national scores)

1: highly favoured

74

18.0

12

16.7

62

18.2

0.101

2: favoured

72

17.5

20

27.8

52

15.3

 

3: intermediate level

96

23.3

11

15.3

85

25

 

4: deprived

89

21.6

17

23.6

72

21.2

 

5: highly deprived

65

15.8

11

15.3

54

15.9

 

missing

16

3.9

1

1.4

15

4.4

 
  1. In bivariate analyses, p-values derived from the chi2 test a.
  2. DLBCL: diffuse large B-cell lymphoma; RDI: relative dose intensity; EDI: European deprivation index.